Stock OPC OPC PHARMACEUTICAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials OPC Pharmaceutical

Equities

OPC

VN000000OPC9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E.
Other stock markets
 18:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
23,950 VND 0.00% Intraday chart for OPC Pharmaceutical -6.08% -0.21%
05-02 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01-30 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,318,233 1,222,555 1,581,348 1,520,220 1,761,400 1,537,221
Enterprise Value (EV) 1 1,328,509 1,249,988 1,568,096 1,373,409 1,446,194 1,215,860
P/E ratio 14.5 x 13.5 x 15 x 12.1 x 13.8 x 14.7 x
Yield 4.03% 6.52% 5.04% - 5.45% -
Capitalization / Revenue 1.31 x 1.24 x 1.64 x 1.35 x 1.5 x 1.53 x
EV / Revenue 1.33 x 1.26 x 1.62 x 1.22 x 1.23 x 1.21 x
EV / EBITDA 9.13 x 8.05 x 9.92 x 7.26 x 7.18 x 7.19 x
EV / FCF 9.46 x 78.9 x 16 x 6.71 x 9.7 x 12.8 x
FCF Yield 10.6% 1.27% 6.26% 14.9% 10.3% 7.78%
Price to Book 2.36 x 1.97 x 2.45 x 2.23 x 2.18 x 1.87 x
Nbr of stocks (in thousands) 64,051 64,051 64,051 64,051 64,051 64,051
Reference price 2 20,581 19,087 24,689 23,734 27,500 24,000
Announcement Date 4/1/19 3/31/20 3/15/21 3/7/22 3/15/23 3/22/24
1VND in Million2VND
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,002,478 989,390 965,591 1,123,728 1,171,614 1,004,887
EBITDA 1 145,465 155,184 158,152 189,215 201,454 169,015
EBIT 1 122,660 129,683 136,411 166,713 178,636 146,120
Operating Margin 12.24% 13.11% 14.13% 14.84% 15.25% 14.54%
Earnings before Tax (EBT) 1 130,246 131,183 132,778 159,241 179,924 155,323
Net income 1 98,145 100,931 105,791 126,377 142,128 122,234
Net margin 9.79% 10.2% 10.96% 11.25% 12.13% 12.16%
EPS 2 1,421 1,411 1,647 1,968 2,000 1,634
Free Cash Flow 1 140,499 15,836 98,161 204,691 149,153 94,622
FCF margin 14.02% 1.6% 10.17% 18.22% 12.73% 9.42%
FCF Conversion (EBITDA) 96.59% 10.2% 62.07% 108.18% 74.04% 55.98%
FCF Conversion (Net income) 143.15% 15.69% 92.79% 161.97% 104.94% 77.41%
Dividend per Share 2 829.9 1,245 1,245 - 1,500 -
Announcement Date 4/1/19 3/31/20 3/15/21 3/7/22 3/15/23 3/22/24
1VND in Million2VND
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 10,276 27,433 - - - -
Net Cash position 1 - - 13,252 146,811 315,205 321,361
Leverage (Debt/EBITDA) 0.0706 x 0.1768 x - - - -
Free Cash Flow 1 140,499 15,836 98,161 204,691 149,153 94,622
ROE (net income / shareholders' equity) 16.8% 15.4% 14.7% 17% 17.6% 13.9%
ROA (Net income/ Total Assets) 6.81% 6.84% 7.31% 8.72% 8.99% 7.29%
Assets 1 1,441,549 1,475,295 1,447,245 1,449,906 1,581,360 1,677,795
Book Value Per Share 2 8,715 9,678 10,080 10,635 12,644 12,833
Cash Flow per Share 2 1,444 970.0 928.0 3,116 1,352 4,594
Capex 1 42,138 27,060 30,821 8,912 7,399 12,042
Capex / Sales 4.2% 2.74% 3.19% 0.79% 0.63% 1.2%
Announcement Date 4/1/19 3/31/20 3/15/21 3/7/22 3/15/23 3/22/24
1VND in Million2VND
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
OPC PHARMACEUTICAL Stock OPC Pharmaceutical
-0.21% 60.28M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.02% 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.80% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.31% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.18% 334B
ABBVIE INC. Stock AbbVie Inc.
+4.78% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.09% 239B
NOVARTIS AG Stock Novartis AG
+9.21% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-3.35% 203B
AMGEN INC. Stock Amgen Inc.
+8.31% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. OPC Stock
  4. Financials OPC Pharmaceutical
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW